These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23877685)

  • 1. Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria.
    Jansen PA; Hermkens PH; Zeeuwen PL; Botman PN; Blaauw RH; Burghout P; van Galen PM; Mouton JW; Rutjes FP; Schalkwijk J
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4794-800. PubMed ID: 23877685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pantothenate derivatives for anti-malarial chemotherapy.
    Pett HE; Jansen PA; Hermkens PH; Botman PN; Beuckens-Schortinghuis CA; Blaauw RH; Graumans W; van de Vegte-Bolmer M; Koolen KM; Rutjes FP; Dechering KJ; Sauerwein RW; Schalkwijk J
    Malar J; 2015 Apr; 14():169. PubMed ID: 25927675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated.
    Spry C; Macuamule C; Lin Z; Virga KG; Lee RE; Strauss E; Saliba KJ
    PLoS One; 2013; 8(2):e54974. PubMed ID: 23405100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical modification of geminal dialkyl substituents on pantothenamides alters antimicrobial activity.
    Hoegl A; Darabi H; Tran E; Awuah E; Kerdo ES; Habib E; Saliba KJ; Auclair K
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3274-7. PubMed ID: 24986662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Pantetheinase-Resistant Pantothenamide Antibacterials: Structural Modification Impacts on PanK Interaction and Mode of Action.
    Barnard L; Mostert KJ; van Otterlo WAL; Strauss E
    ACS Infect Dis; 2018 May; 4(5):736-743. PubMed ID: 29332383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical biology tools to study pantetheinases of the vanin family.
    Schalkwijk J; Jansen P
    Biochem Soc Trans; 2014 Aug; 42(4):1052-5. PubMed ID: 25110001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
    Akinnusi TO; Vong K; Auclair K
    Bioorg Med Chem; 2011 Apr; 19(8):2696-706. PubMed ID: 21440446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria.
    Jansen PAM; van der Krieken DA; Botman PNM; Blaauw RH; Cavina L; Raaijmakers EM; de Heuvel E; Sandrock J; Pennings LJ; Hermkens PHH; Zeeuwen PLJM; Rutjes FPJT; Schalkwijk J
    J Antibiot (Tokyo); 2019 Sep; 72(9):682-692. PubMed ID: 31171848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites.
    Zhang YM; Frank MW; Virga KG; Lee RE; Rock CO; Jackowski S
    J Biol Chem; 2004 Dec; 279(49):50969-75. PubMed ID: 15459190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in pantothenate kinase type determines the pantothenamide mode of action and impacts on coenzyme A salvage biosynthesis.
    de Villiers M; Barnard L; Koekemoer L; Snoep JL; Strauss E
    FEBS J; 2014 Oct; 281(20):4731-53. PubMed ID: 25156889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of Klebsiella pneumoniae pantothenate kinase in complex with N-substituted pantothenamides.
    Li B; Tempel W; Smil D; Bolshan Y; Schapira M; Park HW
    Proteins; 2013 Aug; 81(8):1466-72. PubMed ID: 23553820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
    Balsamo A; Barontini S; Calvani F; Gentili D; Macchia M; Rossello A; Di Modugno E; Felici A
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1035-40. PubMed ID: 10230635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting the coenzyme A biosynthesis pathway for the identification of new antimalarial agents: the case for pantothenamides.
    Saliba KJ; Spry C
    Biochem Soc Trans; 2014 Aug; 42(4):1087-93. PubMed ID: 25110007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials.
    Lohray BB; Lohray VB; Srivastava BK; Gupta S; Solanki M; Pandya P; Kapadnis P
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1557-61. PubMed ID: 16386420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
    Benson CA; Segreti J; Beaudette FE; Hines DW; Goodman LJ; Kaplan RL; Trenholme GM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):328-30. PubMed ID: 2952063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triazole Substitution of a Labile Amide Bond Stabilizes Pantothenamides and Improves Their Antiplasmodial Potency.
    Howieson VM; Tran E; Hoegl A; Fam HL; Fu J; Sivonen K; Li XX; Auclair K; Saliba KJ
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7146-7152. PubMed ID: 27645235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
    Clark C; McGhee P; Appelbaum PC; Kosowska-Shick K
    Antimicrob Agents Chemother; 2011 May; 55(5):2344-51. PubMed ID: 21343467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
    Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria.
    Schmidt EJ; Boswell JS; Walsh JP; Schellenberg MM; Winter TW; Li C; Allman GW; Savage PB
    J Antimicrob Chemother; 2001 May; 47(5):671-4. PubMed ID: 11328782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections.
    Faghih O; Zhang Z; Ranade RM; Gillespie JR; Creason SA; Huang W; Shibata S; Barros-Álvarez X; Verlinde CLMJ; Hol WGJ; Fan E; Buckner FS
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.